• HOME
  • RESEARCH
  • PEOPLE
  • PUBLICATIONS
  • LAB NEWS
  • GALLERY
  • CONTACT
Buhrlage Lab - Cancer Chemical Biology

Sara Buhrlage, PhD
CANCER CHEMICAL BIOLOGY

Welcome to the Buhrlage Lab

Our mission is to develop first-in-class inhibitors and prototype drugs against deubiquitinating enzymes. We harness the power of diverse and complementary techniques for inhibitor discovery: high throughput screening, chemoproteomics, medicinal chemistry, biochemistry, computational chemistry, bioinformatics, and structural analysis. We utilize these inhibitors for phenotypic screens against disease systems encompassing oncology, neurodegeneration, and infectious diseases. Our work has led to a potent and selective USP7 inhibitor that elicits cancer cell death through a p53-dependent mechanism.


Picture
 HOME | RESEARCH | PEOPLE | PUBLICATIONS | LAB NEWS | CONTACT
©2019 Cancer Chemical Biology at Dana-Farber Cancer Institute